[unable to retrieve full-text content] New platform addresses the operational gap that causes 80% of therapeutic launches to underperform, delaying patient access to approved medicines LONDON, ENGLAND, UNITED KINGDOM, May 7, 2026 /⁨EINPresswire.com⁩/ -- BrandLaunchX, a UK-based …

read more